NEW YORK – Sight Diagnostics announced on Wednesday a distribution deal with Phoenix Capital to provide Sight OLO blood analyzers to medical centers in the Middle East.
OLO is a decentralized blood count diagnostic technology that captures more than 1,000 images from two drops of blood from a finger prick or venous sample. The instrument is about the size of a toaster oven and does not require reagents or manual quality control checks.